Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Tucatinib 300 / Capecitabine 1000 / Trastuzumab 6, Breast Cancer, Cycle 2+

Protocol-ID: 1762 V1.1 (Mini), TUCA300/CAPE1000/TRAS6, Breast Ca, C2+

Indication(s)

  • Breast Cancer (HER2+); ICD-10 C50.-
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 19.12.2023